Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2021 Filed Mar 15, 2021 21:18 UTC |
Williams Patrick F.Chief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 5,312 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020524 · doc4.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,312 Underlying: Common Stock · 5,312 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:18 UTC |
Williams Patrick F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020524 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2513 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:17 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 40,932 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020523 · doc4.xml · derivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,932 Underlying: Common Stock · 40,932 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:17 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 19,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020523 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 19,363 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:16 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 5,223 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020522 · doc4.xml · derivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,223 Underlying: Common Stock · 5,223 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:16 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 2,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020522 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2471 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:15 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 9,759 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020521 · doc4.xml · derivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,759 Underlying: Common Stock · 9,759 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:13 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 9,259 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020519 · doc4.xml · derivative · entry 1 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,259 Underlying: Common Stock · 9,259 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:12 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 5,137 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020516 · doc4.xml · derivative · entry 2 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,137 Underlying: Common Stock · 5,137 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:12 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock | 2,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020516 · doc4.xml · nonDerivative · entry 1 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2430 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:11 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 4,585 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020515 · doc4.xml · derivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,585 Underlying: Common Stock · 4,585 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:11 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 2,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020515 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2169 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:10 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 11,154 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020513 · doc4.xml · derivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,154 Underlying: Common Stock · 11,154 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:09 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 6,207 | $0.00 Strike: $90.38 | $0.00 |
DisclosureSEC source: 0001209191-21-020511 · doc4.xml · derivative · entry 5 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,207 Underlying: Common Stock · 6,207 shares Expires 2031-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 21:09 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 2,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020511 · doc4.xml · nonDerivative · entry 3 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Award of 2936 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:09 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 2,665 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001209191-21-020511 · doc4.xml · derivative · entry 4 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,335 Underlying: Common Stock · 2,665 shares Expires 2027-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:09 UTC |
Barnes Scott DChief Medical Officer
|
Disposition to issuerCommon Stock | 2,665 | $92.00 | $245,180.00 |
DisclosureSEC source: 0001209191-21-020511 · doc4.xml · nonDerivative · entry 2 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,390 Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 21:09 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 2,665 | $15.25 | $40,641.25 |
DisclosureSEC source: 0001209191-21-020511 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 2,345 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · derivative · entry 8 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,386 Underlying: Common Stock · 2,345 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 188 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · derivative · entry 7 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124 Underlying: Common Stock · 188 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock Options · Derivative | 4,800 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · derivative · entry 6 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,700 Underlying: Common Stock · 4,800 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Disposition to issuerCommon Stock | 4,033 | $89.25 | $359,945.25 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · nonDerivative · entry 5 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,390 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Disposition to issuerCommon Stock | 3,300 | $88.48 | $291,984.00 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · nonDerivative · entry 4 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,423 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.04 to $89.00, inclusive. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 2,345 | $35.98 | $84,373.10 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · nonDerivative · entry 3 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 188 | $29.80 | $5,602.40 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · nonDerivative · entry 2 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:47 UTC |
Barnes Scott DChief Medical Officer
|
Exercise / conversionCommon Stock | 4,800 | $16.15 | $77,520.00 |
DisclosureSEC source: 0001209191-21-019795 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 45,000 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · derivative · entry 9 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 45,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 45,000 | $98.32 | $4,424,400.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 6 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,013 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.09 to $103.20. Read SEC document |
| March 03, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 45,000 | $7.76 | $349,200.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 5 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 45,000 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · derivative · entry 8 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 45,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 45,000 | $103.53 | $4,658,850.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 4 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,013 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.83 to $106.91. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 45,000 | $7.76 | $349,200.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 3 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:40 UTC |
SILVERMAN LOUDirector
|
SaleCommon Stock | 23,996 | $104.78 | $2,514,300.88 |
DisclosureSEC source: 0001209191-21-016896 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.57 to $106.39, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 45,000 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · derivative · entry 7 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,000 Underlying: Common Stock · 45,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 45,000 | $104.76 | $4,714,200.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,013 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.40 to $106.64. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:39 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 45,000 | $7.76 | $349,200.00 |
DisclosureSEC source: 0001209191-21-016892 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 16,000 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · derivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,026 Underlying: Common Stock · 16,000 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 16,000 | $105.43 | $1,686,880.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:37 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 16,000 | $35.98 | $575,680.00 |
DisclosureSEC source: 0001209191-21-016886 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 3,610 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · derivative · entry 10 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,221 Underlying: Common Stock · 3,610 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 1,873 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · derivative · entry 9 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 Underlying: Common Stock · 1,873 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/13/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 7,094 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · derivative · entry 8 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 Underlying: Common Stock · 7,094 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 1,206 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · derivative · entry 7 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,206 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 13,783 | $104.82 | $1,444,734.06 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 6 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,124 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.14 to $106.56, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 3,610 | $35.98 | $129,887.80 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 5 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 1,873 | $29.80 | $55,815.40 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 4 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 7,094 | $16.15 | $114,568.10 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 3 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 1,206 | $9.30 | $11,215.80 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 5,208 | $103.85 | $540,850.80 |
DisclosureSEC source: 0001209191-21-016890 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,124 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.55 to $106.64, inclusive. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 2,069 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-21-016879 · doc4.xml · derivative · entry 19 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348 Underlying: Common Stock · 2,069 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.